#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA3720853	B	Activity at human T1R1/T1R3 expressed in HEK293T cells co-expressing Galpha15 assessed as induction of left-ward shift of glutamate dose response curve at 1 mM relative to untreated control	Homo sapiens	1		cell-based format	Patent Bioactivity Data
2.	ALA3720854	B	Activity at human T1R1/T1R3 expressed in HEK293T cells co-expressing Galpha15 assessed as induction of left-ward shift of glutamate/IMP dose response curve at 5 mM relative to untreated control	Homo sapiens	1		cell-based format	Patent Bioactivity Data
3.	ALA3720882	B	Activity at human T1R1/T1R3 expressed in HEK293T cells co-expressing Galpha15 assessed as induction of left-ward shift of glutamate dose response curve at 5 mM relative to untreated control	Homo sapiens	1		cell-based format	Patent Bioactivity Data
4.	ALA3720883	F	Inhibition of human T1R1/T1R3 expressed in HEK293T cells co-expressing Galpha15 assessed as calcium response by fluo-4-AM dye based FLIPR assay	Homo sapiens	1		cell-based format	Patent Bioactivity Data
5.	ALA3720884	B	Activation of human T1R1/T1R3 expressed in HEK293T cells co-expressing Galpha15 assessed as induction of left-ward shift of glutamate dose response curve at 5 uM relative to untreated control	Homo sapiens	1		cell-based format	Patent Bioactivity Data
6.	ALA3720885	B	Activation of human T1R1/T1R3 expressed in HEK293T cells co-expressing Galpha15 assessed as induction of left-ward shift of glutamate/IMP dose response curve at 5 uM relative to untreated control	Homo sapiens	1		cell-based format	Patent Bioactivity Data
7.	ALA3720886	B	Inhibition of human T1R1/T1R3 expressed in HEK293T cells co-expressing Galpha15 assessed as reduction in 8 mM L-glutamate-induced response	Homo sapiens	1		cell-based format	Patent Bioactivity Data
8.	ALA3720887	B	Activity at human T1R1/T1R3 expressed in HEK293T cells co-expressing Galpha15 assessed as induction of left-ward shift of glutamate/IMP dose response curve at 1 mM relative to untreated control	Homo sapiens	1		cell-based format	Patent Bioactivity Data
9.	ALA3720888	B	Inhibition of human T1R1/T1R3 expressed in HEK293T cells co-expressing Galpha15 assessed as reduction in 80 mM L-glutamate-induced response	Homo sapiens	1		cell-based format	Patent Bioactivity Data
10.	ALA3720889	B	Inhibition of human T1R1/T1R3 expressed in HEK293T cells co-expressing Galpha15 assessed as reduction in L-glutamate/IMP-induced response in presence of 0.8 mM L-glutamate	Homo sapiens	1		cell-based format	Patent Bioactivity Data
11.	ALA3720890	B	Inhibition of human T1R1/T1R3 expressed in HEK293T cells co-expressing Galpha15 assessed as reduction in L-glutamate/IMP-induced response in presence of 80 mM L-glutamate	Homo sapiens	1		cell-based format	Patent Bioactivity Data
12.	ALA3720891	B	Inhibition of human T1R1/T1R3 expressed in HEK293T cells co-expressing Galpha15 assessed as EC50 for L-glutamate-induced response at 25 uM (Rvb = 9.9 +/-1.5 mM)	Homo sapiens	1		cell-based format	Patent Bioactivity Data
13.	ALA3720892	B	Inhibition of human T1R1/T1R3 expressed in HEK293T cells co-expressing Galpha15 assessed as EC50 for L-glutamate-induced response at 50 uM (Rvb = 9.9 +/-1.5 mM)	Homo sapiens	1		cell-based format	Patent Bioactivity Data
14.	ALA3720893	B	Inhibition of human T1R1/T1R3 expressed in HEK293T cells co-expressing Galpha15 assessed as EC50 for L-glutamate/IMP-induced response at 100 uM (Rvb = 0.53 +/-0.04 mM)	Homo sapiens	1		cell-based format	Patent Bioactivity Data
15.	ALA3720894	B	Inhibition of human T1R1/T1R3 expressed in HEK293T cells co-expressing Galpha15 assessed as EC50 for L-glutamate/IMP-induced response at 200 uM (Rvb = 0.53 +/-0.04 mM)	Homo sapiens	1		cell-based format	Patent Bioactivity Data
16.	ALA3720907	F	Agonist activity at human T1R1/T1R3 expressed in HEK293T cells co-expressing Galpha15 assessed as calcium mobilization by fluo-4-AM dye based FLIPR assay	Homo sapiens	140		cell-based format	Patent Bioactivity Data
17.	ALA3720908	F	Agonist activity at human T1R1/T1R3 expressed in HEK293T cells co-expressing Galpha15 assessed as enhancement of MSG-induced calcium mobilization by measuring ratio of MSG EC50 in presence and absence of 1 uM compound by fluo-4-AM dye based FLIPR assay	Homo sapiens	31		cell-based format	Patent Bioactivity Data
18.	ALA3720909	F	Agonist activity at human T1R1/T1R3 expressed in HEK293T cells co-expressing Galpha15 assessed as enhancement of MSG-induced calcium mobilization by measuring ratio of MSG EC50 in presence and absence of 0.01 uM compound by fluo-4-AM dye based FLIPR assay	Homo sapiens	1		cell-based format	Patent Bioactivity Data
19.	ALA3720937	F	Agonist activity at human T1R1/T1R3 expressed in HEK293T cells co-expressing Galpha15 assessed as enhancement of MSG-induced calcium mobilization by measuring ratio of MSG EC50 in presence and absence of 0.03 uM compound by fluo-4-AM dye based FLIPR assay	Homo sapiens	1		cell-based format	Patent Bioactivity Data
20.	ALA3720938	F	Agonist activity at human T1R1/T1R3 expressed in HEK293T cells co-expressing Galpha15 assessed as enhancement of MSG-induced calcium mobilization by measuring ratio of MSG EC50 in presence and absence of 0.3 uM compound by fluo-4-AM dye based FLIPR assay	Homo sapiens	10		cell-based format	Patent Bioactivity Data